JAMA August 2024 PMID 38864155

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial.

Joel M Dulhunty, Stephen J Brett, Jan J De Waele, Dorrilyn Rajbhandari, Laurent Billot, Menino O Cotta, Joshua S Davis, Simon Finfer, Naomi E Hammond, Serena Knowles, Xiaoqiu Liu, Shay McGuinness, Jayanthi Mysore, David L Paterson, Sandra Peake

Mentions

249
Peak: 86 in Jun 2024
across 7 sources since Jun 2024

Extended reach

2,756,823
potential audience

Total likes

677

Video views

11,432

Mentions per month

Jun 2024 – Sep 2025

Where it's discussed

  • X / Twitter196 posts
  • News27 articles
  • YouTube11 videos
  • Blogs5 articles
  • Bluesky4 posts
  • Facebook4 posts
  • Reddit2 posts

AI synopsis

What people are saying

The overall tone demonstrates a neutral recognition of the study's key conclusion—no significant difference in mortality—while some posts explore secondary outcomes and methodological details. Words like 'out' and references to conferences like #CCR24 and @JAMA_current contribute to a tone of dissemination and mild interest, with some participation indicating genuine curiosity but limited deep debate.

AgreementNeither agree nor disagree

Most discussions acknowledge the study's findings that continuous versus intermittent infusion did not significantly affect mortality, reflecting cautious acceptance of the results.

InterestModerate interest

Posts show moderate curiosity, with many summarizing key points and referencing the trial, but few deeply analyze implications.

EngagementModerate engagement

Several discussions include references to the trial details, methodology, or related conferences, indicating active engagement, though not highly critical or profound.

ImpactModerate impact

The widespread sharing and discussion at conferences and in prominent medical circles suggest the study has some influence, but the limited later consequences imply a moderate impact.

Abstract in brief

  • A study investigated if continuous infusion of β-lactam antibiotics reduces death risk in critically ill sepsis patients, comparing this method to intermittent infusion.
  • Conducted in 104 ICUs across several countries from 2018 to 2023, the trial involved over 7,200 participants receiving either piperacillin-tazobactam or meropenem.
  • Results showed a slight decrease in 90-day mortality for continuous infusion (24.9%) versus intermittent infusion (26.8%), but the difference was not statistically significant (-1.9% difference).

Top posts

Most liked on X and Bluesky
S.Enf.Infecciosas HRUM
@infeccHRUmalaga · X

Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 162 likes · 48 shares · 6,492 followers View post →
高槻病院・井上病院・しんあいクリニック 総合内科
@Takatsuki_GIM · X

敗血症に抗菌薬の間欠vs持続 10.1001/jama.2024.9779 過去に複数の間欠vs持続研究あり 今回過去最大規模RCT BLING III P: 重症敗血症 I: β-L (PIPC/TAZ or MEPM)持続 C: 間欠 O: 90死亡、治癒 結果:死亡有意差なし、持続で臨床的治癒率が高い これまでの試験を統合したメタ解析を見たいです https://t.co/xMuioVW8Gt

Jun 28, 2024 · 84 likes · 11 shares · 6,326 followers View post →
JAMA
@JAMA_current · X

BLING III: In critically ill patients with sepsis, continuous vs intermittent β-lactam antibiotic infusions did not significantly reduce 90-day mortality. https://t.co/s2wdF1Qg2b https://t.co/luhusWZ7fJ

Aug 31, 2024 · 34 likes · 14 shares · 487,767 followers View post →
ACCP INFD PRN
@accpinfdprn · X

BLING III is out!

Jun 12, 2024 · 32 likes · 9 shares · 13,670 followers View post →
PROA_Marañón
@PROA_maran · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/ByNyXaFpOe

Jun 12, 2024 · 28 likes · 12 shares · 4,106 followers View post →
Michael Calderwood, MD, MPH
@CalderwoodMD · X

1/5 Most influential 2024 #abxstewardship papers presented by @tinymuscles at #IDWeek2024: Ongoing evidence supporting prolonged/continuous infusion of beta-lactam abx, BUT higher risk of catheter complications & abx side effects. https://t.co/9LXLEmzfjB, https://t.co/CyNyA2TdtA

Oct 19, 2024 · 27 likes · 11 shares · 3,213 followers View post →

All mentions

SOHall
@SOHall483472 · X

RT @PittCCM: He presented: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III R…

Jul 5, 2025 · 1 share View post →
Dr. Andrés Neira
@mandresneiraf · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

Jun 13, 2025 · 48 shares · 57 followers View post →
官澤洋平 YK Hospitalist
@Yohei_Kanzawa · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/kMCbxSR2l5

Jun 12, 2025 · 5 likes · 3,197 followers View post →
Silvia Garcia B
@SilviaGarciaB1 · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 29, 2025 · 48 shares · 289 followers View post →
Marco Banda Lara
@DrMarcoBanda · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 28, 2025 · 48 shares · 137 followers View post →
Tony Boral
@Dr_TonyBoral · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 28, 2025 · 48 shares · 175 followers View post →
ParraJanepamd
@ParraJanepamd · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 28, 2025 · 48 shares · 472 followers View post →
Zabdiel Gutierrez
@gzabdiel24 · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 28, 2025 · 48 shares · 76 followers View post →
Dr. Cafeína
@DCafeina · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 28, 2025 · 48 shares · 117 followers View post →
Eddie Giampiere Díaz Carrión
@Edge2114 · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 28, 2025 · 48 shares · 123 followers View post →
Gabriel Rodriguez
@GaboRodriguez85 · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 28, 2025 · 48 shares · 786 followers View post →
Andres Herrera F.
@andresmtbr · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 28, 2025 · 48 shares · 305 followers View post →
CIMES
@cimesalvador · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 1,491 followers View post →
Malvado dr. quesillo
@trama_doc · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 98 followers View post →
Paulina Feola
@paulyhcm · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 636 followers View post →
Alicia Hidalgo Jiménez
@alihidjim · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 4 followers View post →
Trudy Idrovo Rojas
@TrudyIdrovo · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 46 followers View post →
César Díaz
@Cdiacam · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 326 followers View post →
Ana Cris
@AnaCrisA_R · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 577 followers View post →
Mª Dolores Díaz
@mdialop1 · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 114 followers View post →
jose david u brito MD MSc-VIVA O SUS!
@davidbsb1 · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 1,189 followers View post →
María Martín Bautista
@maria_marbau · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 89 followers View post →
Camilo Rincon Millan
@xmilocox88 · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 196 followers View post →
Jesús.
@G_sus93 · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 444 followers View post →
Luis M. Ruiz
@lumoruve · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 297 followers View post →
Alexander Avila
@Alexand46739413 · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 270 followers View post →
Dr. Abraham Katime Zuñiga
@katimeinfecto · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 1,978 followers View post →
Rafael Gálvez/
@Ragachica · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 2,623 followers View post →
Jesus Rodriguez Baño
@jesusrbano · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 7,877 followers View post →
ZagasYum
@zagasyum18 · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 209 followers View post →
Pablo Muñoz Torres
@PamT90 · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 58 followers View post →
Julian mauricio Baez
@jbaez311 · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 29 followers View post →
Brenda M. ♡
@BrendaCMD · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 826 followers View post →
Edgar Reyes
@edgarreyesgar · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 208 followers View post →
Wasili Carrillo
@DrWasili · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 1,814 followers View post →
Paul Abril
@Polandresito · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 85 followers View post →
Infectolocus
@klauprez · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 32 followers View post →
INNOVACIONES
@foxmackalister · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 828 followers View post →
Reme Marqués
@RemeMarques · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 335 followers View post →
Miguel Ángel Amor
@Miguelamorg · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 1,883 followers View post →
Almansour
@malmansour81 · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 205 followers View post →
Goiko-j
@GoikoJ97420 · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 38 followers View post →
Nicolás Montúfar
@NicoMontufar11 · X

RT @infeccHRUmalaga: Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 48 shares · 446 followers View post →
S.Enf.Infecciosas HRUM
@infeccHRUmalaga · X

Fin @SEIMC_ 2025, como despedida los 10 trabajos

May 27, 2025 · 162 likes · 48 shares · 6,492 followers View post →
S.Enf.Infecciosas HRUM
@infeccHRUmalaga · X

2️⃣ BLactamicos en perfusion continua

Apr 14, 2025 · 4 likes · 6,492 followers View post →
Francesc Puchades
@FrancescPuchad2 · X

2.-Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis. The BLING III Randomized Clinical Trial. https://t.co/pT5mfwNsOF

Apr 13, 2025 · 29 followers View post →
K.Ishikawa, MD, Ph.D, MPH, MSc
@hiro_0921jp · X

Continuous vs intermittent β-lactam antibiotic infusions in critically ill patients with sepsis. The BLING III randomized clinical trial. Dulhunty et al., 2024 (JAMA) https://t.co/yXLXwB3Uo5

Apr 12, 2025 · 12 likes · 787 followers View post →
Prof Carol Hodgson
@chodgsonANZICRC · X

RT @ICUnutrition: ANZICS CTG research (led or contributing) reaching far and wide, presented in Kuwait in the year in review BLING https:/…

Feb 1, 2025 · 3 shares · 3,306 followers View post →
Abdulrahman Al-Fares
@AAlFares79 · X

RT @ICUnutrition: ANZICS CTG research (led or contributing) reaching far and wide, presented in Kuwait in the year in review BLING https:/…

Feb 1, 2025 · 3 shares · 1,199 followers View post →
CriticalCareKuwait
@CriticalCareQ8 · X

RT @ICUnutrition: ANZICS CTG research (led or contributing) reaching far and wide, presented in Kuwait in the year in review BLING https:/…

Feb 1, 2025 · 3 shares · 177 followers View post →
A/Prof Emma Ridley
@ICUnutrition · X

ANZICS CTG research (led or contributing) reaching far and wide, presented in Kuwait in the year in review BLING https://t.co/IShyVWidRT BALANCE https://t.co/AyoAwID9QH @CriticalCareQ8 @anzicsctg @georgeinstitute @NaomiHammond

Feb 1, 2025 · 7 likes · 3 shares · 3,471 followers View post →
Hide
@1958625 · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/zElyyTAf0T

Jan 10, 2025 · 1 like · 360 followers View post →
JAMA
@jama.com · Bluesky

Most Viewed JAMA 2024: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With #Sepsis

Dec 30, 2024 · 1 like · 1 share View post →
Arturo Aleman
@ElArturoAleman · X

RT @JAMA_current: @LRSorce @SebastianPalmqv @NiklasMattsson4 Most Viewed JAMA 2024: Continuous vs Intermittent β-Lactam Antibiotic Infusion…

Dec 30, 2024 · 1 share · 402 followers View post →
JAMA
@JAMA_current · X

@LRSorce @SebastianPalmqv @NiklasMattsson4 Most Viewed JAMA 2024: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With #Sepsis

Dec 30, 2024 · 7 likes · 1 share · 487,767 followers View post →
Pitt Critical Care Medicine
@PittCCM · X

He presented: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial.  #pittccm #upmc #journalclub #ccm #criticalcaremedicine #pittschoolofmedicine #intensivist #criticalcare #pittsburghccm #fellow https://t.co/lsVbNqx7vJ

Dec 19, 2024 · 2 likes · 1 share · 3,698 followers View post →
JAMA
@jama.com · Bluesky

Original Investigation: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis | The BLING III Randomized Clinical Trial jamanetwork.com/journals/jam...

Dec 19, 2024 · 1 like · 1 share View post →
Carlos Enrique Tairo Cerron
@TairoCerron2024 · X

RT @JAMA_current: Original Investigation: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis |…

Dec 19, 2024 · 1 share · 71 followers View post →
JAMA
@JAMA_current · X

Original Investigation: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis | The BLING III Randomized Clinical Trial https://t.co/OgGY97DhG4 https://t.co/0YNWdzwuOO

Dec 19, 2024 · 6 likes · 1 share · 487,767 followers View post →
Hitoshi Honda
@Tokotoko1807 · X

https://t.co/fexDfoDx7n

Dec 17, 2024 · 1 like · 248 followers View post →
William F Wright
@wwrighid.bsky.social · Bluesky

#IDSky #PharmSky #MicroSky

Nov 25, 2024 · 2 likes View post →
S. Evan Cooper
@scooper-id.bsky.social · Bluesky

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial jamanetwork.com/journals/jam...

Nov 22, 2024 · 1 share View post →
DASON
@DASON_duke · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With SepsisThe BLING III Randomized Clinical Trial https://t.co/PjkUHa88CJ

Nov 21, 2024 · 1 like · 2,178 followers View post →
Andy Conway Morris
@andymoz78 · X

RT @SCCM_CPP: #CPPPLU Highlights: The BLING III RCT in @JAMA_current by @criticcaredoc et al. found no difference in 90-day mortality but i…

Oct 31, 2024 · 1 share · 14,432 followers View post →
SCCM Clinical Pharmacy and Pharmacology Section
@SCCM_CPP · X

#CPPPLU Highlights: The BLING III RCT in @JAMA_current by @criticcaredoc et al. found no difference in 90-day mortality but improved clinical cure with continuous infusion beta-lactams in ICU patients with sepsis. https://t.co/scAVId0TuD #PharmICU https://t.co/Qr2dQjR4JM

Oct 31, 2024 · 4 likes · 1 share · 3,412 followers View post →
Eddie Giampiere Díaz Carrión
@Edge2114 · X

RT @CalderwoodMD: 1/5 Most influential 2024 #abxstewardship papers presented by @tinymuscles at #IDWeek2024: Ongoing evidence supporting pr…

Oct 20, 2024 · 11 shares · 123 followers View post →
John Choi
@JohnChoi_HKU · X

RT @CalderwoodMD: 1/5 Most influential 2024 #abxstewardship papers presented by @tinymuscles at #IDWeek2024: Ongoing evidence supporting pr…

Oct 20, 2024 · 11 shares · 27 followers View post →
N.Theerawat
@naksanguan · X

RT @CalderwoodMD: 1/5 Most influential 2024 #abxstewardship papers presented by @tinymuscles at #IDWeek2024: Ongoing evidence supporting pr…

Oct 19, 2024 · 11 shares · 35 followers View post →
Nhi Nguyen, PharmD
@Nhitrofurantoin · X

RT @CalderwoodMD: 1/5 Most influential 2024 #abxstewardship papers presented by @tinymuscles at #IDWeek2024: Ongoing evidence supporting pr…

Oct 19, 2024 · 11 shares · 76 followers View post →
Melissa Johnson
@IDPharmacist · X

RT @CalderwoodMD: 1/5 Most influential 2024 #abxstewardship papers presented by @tinymuscles at #IDWeek2024: Ongoing evidence supporting pr…

Oct 19, 2024 · 11 shares · 4,141 followers View post →
Javier Saldaña
@Azrael257Javier · X

RT @CalderwoodMD: 1/5 Most influential 2024 #abxstewardship papers presented by @tinymuscles at #IDWeek2024: Ongoing evidence supporting pr…

Oct 19, 2024 · 11 shares · 400 followers View post →
Actinomycetales
@patamonlover · X

RT @CalderwoodMD: 1/5 Most influential 2024 #abxstewardship papers presented by @tinymuscles at #IDWeek2024: Ongoing evidence supporting pr…

Oct 19, 2024 · 11 shares · 76 followers View post →
Blanca E Gonzalez
@infectio01 · X

RT @CalderwoodMD: 1/5 Most influential 2024 #abxstewardship papers presented by @tinymuscles at #IDWeek2024: Ongoing evidence supporting pr…

Oct 19, 2024 · 11 shares · 1,031 followers View post →
Dr.SGanta@PharmD
@SaiduluGanta · X

RT @CalderwoodMD: 1/5 Most influential 2024 #abxstewardship papers presented by @tinymuscles at #IDWeek2024: Ongoing evidence supporting pr…

Oct 19, 2024 · 11 shares · 759 followers View post →
Jonathan Ryder, MD
@JonathanRyderMD · X

RT @CalderwoodMD: 1/5 Most influential 2024 #abxstewardship papers presented by @tinymuscles at #IDWeek2024: Ongoing evidence supporting pr…

Oct 19, 2024 · 11 shares · 2,686 followers View post →
K J Ferraris
@reffeiksirarref · X

RT @CalderwoodMD: 1/5 Most influential 2024 #abxstewardship papers presented by @tinymuscles at #IDWeek2024: Ongoing evidence supporting pr…

Oct 19, 2024 · 11 shares · 540 followers View post →
Michael Calderwood, MD, MPH
@CalderwoodMD · X

1/5 Most influential 2024 #abxstewardship papers presented by @tinymuscles at #IDWeek2024: Ongoing evidence supporting prolonged/continuous infusion of beta-lactam abx, BUT higher risk of catheter complications & abx side effects. https://t.co/9LXLEmzfjB, https://t.co/CyNyA2TdtA

Oct 19, 2024 · 27 likes · 11 shares · 3,213 followers View post →
Juan Carlos del Rio
@juancardelrio · X

RT @chemasalas3: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/Ixx5XcDNNr

Oct 13, 2024 · 1 share · 163 followers View post →
Chema Salas
@chemasalas3 · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/Ixx5XcDNNr

Oct 13, 2024 · 1 like · 1 share · 3,073 followers View post →
薄氷を履む
@_out_on_a_limb2 · X

RT @intensivecare_c: 敗血症による重症患者へのβラクタム系抗菌薬は持続投与?それとも間欠投与? 90日死亡率に有意差はないものの、持続投与の方が良さそうな傾向。 BLING III trial https://t.co/5q7rKAIlf3

Oct 6, 2024 · 7 shares · 12 followers View post →
AMA Ed Hub™
@AMAEdHub · X

New from JN Learning: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/HZuBuF8sDh

Sep 25, 2024 · 11,196 followers View post →
Eduardo López
@DopadoEduar · X

Ensayo BLING III https://t.co/AGlcEtxR8D

Sep 24, 2024 · 1,313 followers View post →
残像
@hanayukitwin · X

RT @Takashi_Matono: JAMA. 2024;332(8):629-637. 一方で、こちらの大規模RCTでは有益性は示せず… https://t.co/rmQwKC3GWO

Sep 14, 2024 · 1 share · 421 followers View post →
的野多加志@感染症専門医
@Takashi_Matono · X

JAMA. 2024;332(8):629-637. 一方で、こちらの大規模RCTでは有益性は示せず… https://t.co/rmQwKC3GWO

Sep 14, 2024 · 6 likes · 1 share · 1,523 followers View post →
Almansour
@malmansour81 · X

RT @ESICM:

Sep 10, 2024 · 1 share · 205 followers View post →
ESICM
@ESICM · X

Sep 9, 2024 · 3 likes · 1 share · 42,477 followers View post →
官澤洋平 YK Hospitalist
@Yohei_Kanzawa · X

①Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial https://t.co/G6FdKVmey7

Sep 6, 2024 · 1 like · 3,197 followers View post →
T.kimura
@jjcrazydiamond · X

RT @JAMA_current: BLING III: In critically ill patients with sepsis, continuous vs intermittent β-lactam antibiotic infusions did not signi…

Aug 31, 2024 · 14 shares · 1,373 followers View post →
Andres Felipe Florez
@Andresffmed · X

RT @JAMA_current: BLING III: In critically ill patients with sepsis, continuous vs intermittent β-lactam antibiotic infusions did not signi…

Aug 31, 2024 · 14 shares · 159 followers View post →
leopold
@leopold48004692 · X

RT @JAMA_current: BLING III: In critically ill patients with sepsis, continuous vs intermittent β-lactam antibiotic infusions did not signi…

Aug 31, 2024 · 14 shares · 9 followers View post →
Rebecca Weitzel
@rweitzel0913 · X

RT @JAMA_current: BLING III: In critically ill patients with sepsis, continuous vs intermittent β-lactam antibiotic infusions did not signi…

Aug 31, 2024 · 14 shares · 981 followers View post →
Bongani Mayosi Health Sciences Library (BMHSL)
@uct_bmhsl · X

RT @JAMA_current: BLING III: In critically ill patients with sepsis, continuous vs intermittent β-lactam antibiotic infusions did not signi…

Aug 31, 2024 · 14 shares · 1,602 followers View post →
Amin Coker
@aCokerVI · X

RT @JAMA_current: BLING III: In critically ill patients with sepsis, continuous vs intermittent β-lactam antibiotic infusions did not signi…

Aug 31, 2024 · 14 shares · 101 followers View post →
Mike Donnino, MD
@mdonnino · X

RT @JAMA_current: BLING III: In critically ill patients with sepsis, continuous vs intermittent β-lactam antibiotic infusions did not signi…

Aug 31, 2024 · 14 shares · 2,305 followers View post →
JAMA
@JAMA_current · X

BLING III: In critically ill patients with sepsis, continuous vs intermittent β-lactam antibiotic infusions did not significantly reduce 90-day mortality. https://t.co/s2wdF1Qg2b https://t.co/luhusWZ7fJ

Aug 31, 2024 · 34 likes · 14 shares · 487,767 followers View post →
ガースー@関節系内科医
@gasu2019koto · X

ICU敗血症患者でPIPC/TAZかMEMPの持続投与は間欠投与に比べて90日後の全死因死亡を減らさず。 一応secondary outcomeの14日後のclinical cureは差ついてるのね。ハードアウトカムで差がつかないならダメなのか、理論と感染症治療的には持続投与のがちょっと良いのか分からん。 https://t.co/YNlFWNCxlB

Aug 29, 2024 · 12 likes · 1 share · 2,022 followers View post →
Isaura R. Penin
@irodriguezpenin · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/VSXeLYynAe

Aug 28, 2024 · 2 likes · 623 followers View post →
AMA Ed Hub™
@AMAEdHub · X

New from Ed Hub Infectious Diseases: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/h8bhh8kNEz

Aug 28, 2024 · 11,196 followers View post →
Santi Mintegi
@MintegiSanti · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/qonWTQZOiD

Aug 28, 2024 · 3 likes · 1,097 followers View post →
Mahdee Sobhanie, MD
@IDRenaissanceMD · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/oGgHqk0UKt

Aug 27, 2024 · 1,174 followers View post →
Un1v3rs0 Z3r0
@Un1v3rs0Z3r0 · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/h4Jkzj1fXO

Aug 27, 2024 · 508 followers View post →
julio braga
@juliobr53983551 · X

RT @WICSBottomLine: #TBL 455: BLING III - Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients with Sepsis…

Aug 22, 2024 · 2 shares · 170 followers View post →
Renee Goh Lyn Nee
@ReneeGohLynNee1 · X

RT @WICSBottomLine: #TBL 455: BLING III - Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients with Sepsis…

Aug 15, 2024 · 2 shares · 11 followers View post →
The Bottom Line
@WICSBottomLine · X

#TBL 455: BLING III - Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients with Sepsis The BLING III Randomized Clinical Trial https://t.co/T9MxdXkkSX Article by Dalhunty Review by Guo #FOAMed #PharmD https://t.co/Mj7HfOig2x

Aug 15, 2024 · 8 likes · 2 shares · 20,816 followers View post →
Anan
@Anan83174H · X

RT @bryanacotton1: Continuous b-lactam infusion had ⬇️

Aug 3, 2024 · 2 shares · 34 followers View post →
Matthieu Jabaudon
@mj0b · X

RT @IcuCast: We talk #BLING3 from #CCR24 and published in @JAMA_current looking at continuous vs intermittent bolus antibiotic dosing of be…

Jul 31, 2024 · 3 shares · 898 followers View post →
Critical Care Reviews
@CritCareReviews · X

RT @IcuCast: We talk #BLING3 from #CCR24 and published in @JAMA_current looking at continuous vs intermittent bolus antibiotic dosing of be…

Jul 31, 2024 · 3 shares · 61,468 followers View post →
Pharmacy To Dose: The Critical Care Podcast
@PharmacyToDose · X

RT @IcuCast: We talk #BLING3 from #CCR24 and published in @JAMA_current looking at continuous vs intermittent bolus antibiotic dosing of be…

Jul 30, 2024 · 3 shares · 6,816 followers View post →
ICUEdandToddCast
@IcuCast · X

We talk #BLING3 from #CCR24 and published in @JAMA_current looking at continuous vs intermittent bolus antibiotic dosing of beta lactams. Honored to be joined by @JoannaCCPharmD! BLING3: https://t.co/43Ey5cb3pJ On your fav podcast app: https://t.co/qPyhTM2Rd4 @CritCareReviews

Jul 30, 2024 · 12 likes · 3 shares · 1,249 followers View post →
Critical Care Pharmacists
@CCPharmacists · X

RT @SCCM_CPP: @SCCM @AlyssaGarelli @EskenaziHealth @of_aic #SCCMJC #PharmICU Presenter 2: Nihad Medar, PharmD @nihadmedar99 PGY2 CC @Brigha…

Jul 18, 2024 · 1 share · 4,496 followers View post →
SCCM Clinical Pharmacy and Pharmacology Section
@SCCM_CPP · X

@SCCM @AlyssaGarelli @EskenaziHealth @of_aic #SCCMJC #PharmICU Presenter 2: Nihad Medar, PharmD @nihadmedar99 PGY2 CC @BrighamWomens Continuous vs Intermittent Beta-Lactam Antibiotic Infusions in Critically Ill Patients with Sepsis: The BLING III RCT @JAMA https://t.co/scAVId0TuD

Jul 18, 2024 · 2 likes · 1 share · 3,412 followers View post →
xxxichiroxxx_ID
@xxxichiroxxx_ID · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Rand… https://t.co/Yoc1u26KkC βラクタム系抗菌薬の持続vs間歇投与の有意性の報告 90日以内全死因死亡は差が無く副次評価項目のうち臨床的治癒率は、持続の方が良かった。

Jul 13, 2024 · 155 followers View post →
Critical Care Pharmacists
@CCPharmacists · X

RT @SCCM_CPP: @SCCM @AlyssaGarelli @EskenaziHealth @of_aic #SCCMJC #PharmICU Presenter 2: Nihad Medar, PharmD @nihadmedar99 PGY2 CC @Brigha…

Jul 12, 2024 · 1 share · 4,496 followers View post →
SCCM Clinical Pharmacy and Pharmacology Section
@SCCM_CPP · X

@SCCM @AlyssaGarelli @EskenaziHealth @of_aic #SCCMJC #PharmICU Presenter 2: Nihad Medar, PharmD @nihadmedar99 PGY2 CC @BrighamWomens Continuous vs Intermittent Beta-Lactam Antibiotic Infusions in Critically Ill Patients with Sepsis: The BLING III RCT @JAMA https://t.co/scAVId0TuD

Jul 12, 2024 · 1 like · 1 share · 3,412 followers View post →
weststop
@savegaze · X

RT @Takatsuki_GIM: 敗血症に抗菌薬の間欠vs持続 10.1001/jama.2024.9779 過去に複数の間欠vs持続研究あり 今回過去最大規模RCT BLING III P: 重症敗血症 I: β-L (PIPC/TAZ or MEPM)持続 C: 間欠…

Jun 29, 2024 · 11 shares · 463 followers View post →
yyguu
@yyguu · X

RT @Takatsuki_GIM: 敗血症に抗菌薬の間欠vs持続 10.1001/jama.2024.9779 過去に複数の間欠vs持続研究あり 今回過去最大規模RCT BLING III P: 重症敗血症 I: β-L (PIPC/TAZ or MEPM)持続 C: 間欠…

Jun 29, 2024 · 11 shares · 517 followers View post →
がたいがでかい
@gataigadekai · X

RT @Takatsuki_GIM: 敗血症に抗菌薬の間欠vs持続 10.1001/jama.2024.9779 過去に複数の間欠vs持続研究あり 今回過去最大規模RCT BLING III P: 重症敗血症 I: β-L (PIPC/TAZ or MEPM)持続 C: 間欠…

Jun 29, 2024 · 11 shares · 413 followers View post →
nekonekoz
@nekonekoz · X

RT @Takatsuki_GIM: 敗血症に抗菌薬の間欠vs持続 10.1001/jama.2024.9779 過去に複数の間欠vs持続研究あり 今回過去最大規模RCT BLING III P: 重症敗血症 I: β-L (PIPC/TAZ or MEPM)持続 C: 間欠…

Jun 28, 2024 · 11 shares · 806 followers View post →
視界明るく
@populanta3 · X

RT @Takatsuki_GIM: 敗血症に抗菌薬の間欠vs持続 10.1001/jama.2024.9779 過去に複数の間欠vs持続研究あり 今回過去最大規模RCT BLING III P: 重症敗血症 I: β-L (PIPC/TAZ or MEPM)持続 C: 間欠…

Jun 28, 2024 · 11 shares · 15 followers View post →
おれんじ色
@orangeiro7 · X

RT @Takatsuki_GIM: 敗血症に抗菌薬の間欠vs持続 10.1001/jama.2024.9779 過去に複数の間欠vs持続研究あり 今回過去最大規模RCT BLING III P: 重症敗血症 I: β-L (PIPC/TAZ or MEPM)持続 C: 間欠…

Jun 28, 2024 · 11 shares · 1,799 followers View post →
濱田治| 横糸紡ぐ内科医
@chan_hama_osamu · X

RT @Takatsuki_GIM: 敗血症に抗菌薬の間欠vs持続 10.1001/jama.2024.9779 過去に複数の間欠vs持続研究あり 今回過去最大規模RCT BLING III P: 重症敗血症 I: β-L (PIPC/TAZ or MEPM)持続 C: 間欠…

Jun 28, 2024 · 11 shares · 1,248 followers View post →
高槻病院・井上病院・しんあいクリニック 総合内科
@Takatsuki_GIM · X

敗血症に抗菌薬の間欠vs持続 10.1001/jama.2024.9779 過去に複数の間欠vs持続研究あり 今回過去最大規模RCT BLING III P: 重症敗血症 I: β-L (PIPC/TAZ or MEPM)持続 C: 間欠 O: 90死亡、治癒 結果:死亡有意差なし、持続で臨床的治癒率が高い これまでの試験を統合したメタ解析を見たいです https://t.co/xMuioVW8Gt

Jun 28, 2024 · 84 likes · 11 shares · 6,326 followers View post →
Marina Varela Durán
@MarinaVarelaDu1 · X

RT @KatiaDonadello: Here we are for this 2nd day #EUROASIA2024 conference. @criticcaredoc stricking on beta-lactam continuous infusion in c…

Jun 27, 2024 · 6 shares · 2,319 followers View post →
nur 'izzati ahmad za
@anurizzati · X

RT @CritCareReviews: The BLING III trialists summarise their presentation from CCR24 this morning Simultaneously published in @JAMA_curren…

Jun 27, 2024 · 33 shares · 41 followers View post →
Anirban Bhattacharjee MBBS MD DM IDCCM EDIC
@icu_bug · X

Reference doi (

Jun 27, 2024 · 60 followers View post →
Alasdair Munro
@apsmunro · X

@ADAlthousePhD @DavidHarrison80 @gushamilton @statsepi @jd_wilko Especially in case you do a whoopsu and make the unadjusted analysis your primary outcome and miss the magic p value Another excellent, excellent teaching case https://t.co/z6PPvT7eoU

Jun 26, 2024 · 1 like · 53,016 followers View post →
Rocio asensi
@rocioasensi · X

RT @infeccHRUmalaga: Después dl MERCY(Meropenem en pacientes críticos)en @JAMA_current otro ensayo clínico

Jun 25, 2024 · 44 shares · 501 followers View post →
John
@Johnnymzito · X

RT @ABsteward:

Jun 23, 2024 · 86 shares · 81 followers View post →
prim. Ina Filipović-Grčić, M.D.
@inafgyahoocom1 · X

RT @KatiaDonadello: Here we are for this 2nd day #EUROASIA2024 conference. @criticcaredoc stricking on beta-lactam continuous infusion in c…

Jun 23, 2024 · 6 shares · 501 followers View post →
Jan De Waele MD
@criticcaredoc · X

RT @KatiaDonadello: Here we are for this 2nd day #EUROASIA2024 conference. @criticcaredoc stricking on beta-lactam continuous infusion in c…

Jun 23, 2024 · 6 shares · 7,995 followers View post →
Silvia De Rosa
@SilviaDeRosa11 · X

RT @KatiaDonadello: Here we are for this 2nd day #EUROASIA2024 conference. @criticcaredoc stricking on beta-lactam continuous infusion in c…

Jun 23, 2024 · 6 shares · 841 followers View post →
Mike vonTschudi
@ICUStat · X

RT @KatiaDonadello: Here we are for this 2nd day #EUROASIA2024 conference. @criticcaredoc stricking on beta-lactam continuous infusion in c…

Jun 23, 2024 · 6 shares · 2,201 followers View post →
ESICM
@ESICM · X

RT @KatiaDonadello: Here we are for this 2nd day #EUROASIA2024 conference. @criticcaredoc stricking on beta-lactam continuous infusion in c…

Jun 23, 2024 · 6 shares · 42,477 followers View post →
Katia Donadello
@KatiaDonadello · X

Here we are for this 2nd day #EUROASIA2024 conference. @criticcaredoc stricking on beta-lactam continuous infusion in critically ill patients, from PK/PD to clinical practice. Latest research 1. BLING III RCT continuous vs intermittent infusion MER/PIPTAZ https://t.co/cj2LYvDXfE https://t.co/oo66MYOj7n

Jun 23, 2024 · 15 likes · 6 shares · 1,202 followers View post →
the paper link
@the_paper_link · X

Trend up+39: Dulhunty JM, ..., Bling III Study Investigators (JAMA) __Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial__ https://t.co/yqsiABY2hd

Jun 22, 2024 · 137 followers View post →
Michael Angarone
@mangarone23 · X

RT @ABsteward:

Jun 22, 2024 · 86 shares · 1,606 followers View post →
Antibiotic Steward Bassam Ghanem
@ABsteward · X

RT @ABsteward:

Jun 22, 2024 · 86 shares · 59,495 followers View post →
SMMCmicromadrid
@SMMCmicromadrid · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/6lZ8cFocps https://t.co/eETZ1mn549

Jun 21, 2024 · 2,314 followers View post →
Satoru Mitsuboshi
@3stars67664378 · X

RT @pinacol: 【RCT】敗血症患者へのピペラシリン-タゾバクタムまたはメロペネムの持続注入は、間欠注入と比較して、90日死亡率を改善させなかった。 #ペ読 https://t.co/50mxrtURFp

Jun 20, 2024 · 1 share · 1,777 followers View post →
通りすがりの麻酔科医
@torisugari_anes · X

https://t.co/inhfGJ9uB2 ICUにおいて敗血症患者に対し抗生剤(PIPC/TAZorMEPM)の持続投与or間欠投与で90日死亡率が変わるかを調べたRCT 結果は両群間で差はなかった(24.9vs26.9%;差:-1.9[-4.9to1.1]%)臨床的治癒率は持続群で良かった(55.7vs50.0%;差:5.7[2.4-9.1]%) #当麻_感染

Jun 19, 2024 · 2 likes · 2,032 followers View post →
izzati zawawi
@izzatizawawi · X

RT @ABsteward:

Jun 19, 2024 · 86 shares · 27 followers View post →
PubMed Trending
@PubTrend · X

Trending on PubMed: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial. https://t.co/GEykf0IHZa

Jun 18, 2024 · 5,156 followers View post →
Vikesh Gudka
@PharmaVik · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/n1VyAQtGS5

Jun 18, 2024 · 200 followers View post →
ISICEM
@ISICEM · X

@ISICEM Critical Care Input Continuous vs Intermittent β-Lactam #Antibiotic Infusions in Critically Ill Patients With #Sepsis: The BLING III Randomized Clinical Trial #ISICEMelearning #Meded @JAMANetworkOpen #CriticalCare

Jun 18, 2024 · 1 like · 10,896 followers View post →
Sepsis Australia
@sepsisAU · X

RT @CritCareReviews: The BLING III trialists summarise their presentation from CCR24 this morning Simultaneously published in @JAMA_curren…

Jun 17, 2024 · 33 shares · 1,500 followers View post →
Danny McAuley
@dfmcauley · X

RT @MMarmiere: 3/ #BLINGIII

Jun 17, 2024 · 2 shares · 1,815 followers View post →
pediatriaperu
@PediatriaPeru · X

RT @ndanmontero: Enfoque a la infusión IV continua de beta lactámicos en pacientes en el espectro de la sepsis. Continuous vs Intermittent…

Jun 17, 2024 · 2 shares · 201 followers View post →
Bernardo
@bernyboy · X

RT @CritCareReviews: The BLING III trialists summarise their presentation from CCR24 this morning Simultaneously published in @JAMA_curren…

Jun 16, 2024 · 33 shares · 107 followers View post →
Giovanni Landoni, MD
@giovannilandoni · X

RT @MMarmiere: 3/ #BLINGIII

Jun 16, 2024 · 2 shares · 4,668 followers View post →
Marilena Marmiere, MD
@MMarmiere · X

3/ #BLINGIII

Jun 16, 2024 · 4 likes · 2 shares · 600 followers View post →
pinacol
@pinacol · X

【RCT】敗血症患者へのピペラシリン-タゾバクタムまたはメロペネムの持続注入は、間欠注入と比較して、90日死亡率を改善させなかった。 #ペ読 https://t.co/50mxrtURFp

Jun 16, 2024 · 3 likes · 1 share · 1,611 followers View post →
E.Esteve
@Erika_ies · X

RT @infeccHRUmalaga: Después dl MERCY(Meropenem en pacientes críticos)en @JAMA_current otro ensayo clínico

Jun 16, 2024 · 44 shares · 116 followers View post →
Hiroki Hadano
@tkisogib4 · X

#REVISE 挿管中のPPI投与で死亡率変わらず、上部消化管出血減らす https://t.co/gZyrXJiSCD JAMA #BLING III 敗血症へβラクタム系持続で90日死亡率変わらず https://t.co/8BAQNjMyTt #DEFENDER 循環呼吸腎不全患者にフォシーガ10㎎で臨床転帰変わらず https://t.co/TnZL0HRf4S

Jun 16, 2024 · 145 followers View post →
Pravin Amin MD, FCCM, FNCS.
@AminPravin · X

https://t.co/nSszLDLe4I Intermittent vs continous infusion of Beta-lactum antibiotics and mortality @JAMA_current https://t.co/L972jXdWXm

Jun 16, 2024 · 260 followers View post →
BizarrMD
@DrAntonioSilva1 · X

RT @ABsteward:

Jun 15, 2024 · 86 shares · 303 followers View post →
VERÓNICA s
@VERNICANEZ11 · X

RT @ndanmontero: Enfoque a la infusión IV continua de beta lactámicos en pacientes en el espectro de la sepsis. Continuous vs Intermittent…

Jun 15, 2024 · 2 shares · 747 followers View post →
Daniel Montero
@ndanmontero · X

Enfoque a la infusión IV continua de beta lactámicos en pacientes en el espectro de la sepsis. Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis JAMA June 12, 2024. https://t.co/Udxf1VJgni

Jun 15, 2024 · 7 likes · 2 shares · 4,677 followers View post →
Tom Hsiung
@TomHsiung · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/g08oJ1SSYw

Jun 14, 2024 · 1 like · 461 followers View post →
ISICEM
@ISICEM · X

@ISICEM Critical Care Input Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With #Sepsis The BLING III Randomized Clinical Trial #ISICEMelearning @JAMANetworkOpen #Meded https://t.co/Lw97JTSneV https://t.co/RXftosA6JE

Jun 14, 2024 · 4 likes · 10,896 followers View post →
Abstream
@abstreamme · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis #science #publication #research #publications https://t.co/RYAT9JBFq2

Jun 13, 2024 · 784 followers View post →
ごまだパパ
@tyunennishi · X

RT @carpe_diem0820: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis BLING III 試験において、βラクタム…

Jun 13, 2024 · 2 shares · 19 followers View post →
Salvador Valero
@Proa_a2 · X

RT @PROA_maran: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/ByNyXaFpOe

Jun 13, 2024 · 12 shares · 2 followers View post →
VOSTJP
@bee_turquoise · X

RT @carpe_diem0820: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis BLING III 試験において、βラクタム…

Jun 13, 2024 · 2 shares · 146 followers View post →
Mugen UJIIE (氏家 無限)
@carpe_diem0820 · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis BLING III 試験において、βラクタム系抗菌薬の持続点滴と間欠点滴が、重度の敗血症患者の 90 日死亡率に及ぼす影響を評価された。 104の施設のICU で 7,031 https://t.co/0Di9psRsTx

Jun 13, 2024 · 5 likes · 2 shares · 12,385 followers View post →
Aisha A. Alharbi
@AlharbiAisha_ · X

RT @accpinfdprn: BLING III is out!

Jun 13, 2024 · 9 shares · 5,368 followers View post →
Yuriko Yui
@YurikoYui3 · X

RT @PROA_maran: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/ByNyXaFpOe

Jun 13, 2024 · 12 shares · 27 followers View post →
ana f ribera
@ribera367 · X

RT @PROA_maran: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/ByNyXaFpOe

Jun 13, 2024 · 12 shares · 462 followers View post →
Francesc Formiga
@FormigaFrancesc · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/3MoXZ7X8rX

Jun 13, 2024 · 1,941 followers View post →
Shweta Anjan
@shwetanjan · X

RT @CarlosdelRio7: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis @JAMA_current https://t…

Jun 12, 2024 · 2 shares · 483 followers View post →
Brent C. Beckner PharmD, BCPS, BCCCP
@BCB_PharmD · X

RT @accpinfdprn: BLING III is out!

Jun 12, 2024 · 9 shares · 839 followers View post →
Emily Siegrist
@Emily_Siegrist · X

RT @accpinfdprn: BLING III is out!

Jun 12, 2024 · 9 shares · 88 followers View post →
SultanSBAlSA
@SultanSBAlSA · X

RT @accpinfdprn: BLING III is out!

Jun 12, 2024 · 9 shares · 46 followers View post →
Mark Bagnall PhD FRCS
@MarkBagnallSurg · X

RT @bryanacotton1: Continuous b-lactam infusion had ⬇️

Jun 12, 2024 · 2 shares · 2,825 followers View post →
Joel Kennedy
@JFKPharmD · X

RT @accpinfdprn: BLING III is out!

Jun 12, 2024 · 9 shares · 35 followers View post →
Suspicious Corgi
@JoshuaS97888747 · X

RT @accpinfdprn: BLING III is out!

Jun 12, 2024 · 9 shares · 13 followers View post →
Servei de Farmàcia Parc Taulí
@FarmaciaTauli · X

RT @petita_libelula: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/eBP9W58UoY

Jun 12, 2024 · 1 share · 697 followers View post →
Sara D. PharmD
@SaraDiTursi · X

RT @accpinfdprn: BLING III is out!

Jun 12, 2024 · 9 shares · 968 followers View post →
Justin Moore
@moore_wjustin · X

RT @accpinfdprn: BLING III is out!

Jun 12, 2024 · 9 shares · 1,848 followers View post →
ACCP INFD PRN
@accpinfdprn · X

BLING III is out!

Jun 12, 2024 · 32 likes · 9 shares · 13,670 followers View post →
Mauricio Cantillano
@CantillMauricio · X

RT @PROA_maran: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/ByNyXaFpOe

Jun 12, 2024 · 12 shares · 3,584 followers View post →
Bryan Cotton
@bryanacotton1 · X

Continuous b-lactam infusion had ⬇️

Jun 12, 2024 · 9 likes · 2 shares · 5,039 followers View post →
Sayed Abdulmotaleb
@sayedmousawi_ · X

RT @JAMA_current: @jasonroberts_pk @PreetiNMalani Read the Original Investigation “Continuous vs Intermittent β-Lactam Antibiotic Infusions…

Jun 12, 2024 · 1 share · 419 followers View post →
Meri M
@MeriBlody · X

RT @PROA_maran: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/ByNyXaFpOe

Jun 12, 2024 · 12 shares · 785 followers View post →
Xavier Sáez Llorens
@xsaezll · X

RT @CarlosdelRio7: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis @JAMA_current https://t…

Jun 12, 2024 · 2 shares · 128,643 followers View post →
Mª Dolores Díaz
@mdialop1 · X

RT @PROA_maran: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/ByNyXaFpOe

Jun 12, 2024 · 12 shares · 114 followers View post →
Carlos del Rio
@CarlosdelRio7 · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis @JAMA_current https://t.co/0rfZOeaz5v "In critically ill patients with sepsis, continuous vs intermittent β-lactam antibiotic infusions did not significantly reduce 90-day mortality."

Jun 12, 2024 · 4 likes · 2 shares · 55,716 followers View post →
Isaura R. Penin
@irodriguezpenin · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/MOniOKVqan

Jun 12, 2024 · 2 likes · 623 followers View post →
jose luis anton
@joseluisanton3 · X

RT @PROA_maran: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/ByNyXaFpOe

Jun 12, 2024 · 12 shares · 493 followers View post →
JAMA
@JAMA_current · X

@jasonroberts_pk @PreetiNMalani Read the Original Investigation “Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis.” https://t.co/McXAsI3yEo

Jun 12, 2024 · 5 likes · 1 share · 487,767 followers View post →
María Moral
@twittmariamoral · X

RT @PROA_maran: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/ByNyXaFpOe

Jun 12, 2024 · 12 shares · 853 followers View post →
Piluca Martin-Davila
@DavilaPiluca · X

RT @PROA_maran: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/ByNyXaFpOe

Jun 12, 2024 · 12 shares · 609 followers View post →
Sara Ortonobes
@petita_libelula · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/eBP9W58UoY

Jun 12, 2024 · 1 like · 1 share · 388 followers View post →
Luis M. Ruiz
@lumoruve · X

RT @PROA_maran: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/ByNyXaFpOe

Jun 12, 2024 · 12 shares · 297 followers View post →
SEIP
@seipweb · X

RT @PROA_maran: Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/ByNyXaFpOe

Jun 12, 2024 · 12 shares · 12,404 followers View post →
PROA_Marañón
@PROA_maran · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis https://t.co/ByNyXaFpOe

Jun 12, 2024 · 28 likes · 12 shares · 4,106 followers View post →
メーテル|薬剤師
@pharm_ori24 · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/kKTIrm448r

Jun 12, 2024 · 1 like · 364 followers View post →
Dr.Marlon Villanueva™
@MarlonVFZR · X

⏱️⚗️Infusiones prolongadas vs. intermitentes de β-lactámicos en adultos con sepsis o shock séptico

Jun 12, 2024 · 1 like · 5,140 followers View post →
Dr.Marlon Villanueva™
@MarlonVFZR · X

⏱️⚗️Infusiones prolongadas vs. intermitentes de β-lactámicos en adultos con sepsis o shock séptico

Jun 12, 2024 · 5,140 followers View post →
Dave Roberts
@CDifficile1 · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial - PubMed https://t.co/GhJg6ce24t #cdi #cdiff

Jun 12, 2024 · 436 followers View post →
Dr. Almohaizeie
@mohaizeie · X

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/CwcGtz31Rt

Jun 12, 2024 · 296 followers View post →